title: Treatment of In-Stent restenosis using a stent with non-polymer-based paclitaxel elution.
abstract: Treatment of in-stent restenosis remains a therapeutic challenge. Twenty-seven lesions with in-stent restenosis were treated with non-polymer-based paclitaxel-eluting stents. At 6-month follow-up, in-stent late loss was 0.44 +/- 0.54 mm and the restenosis rate was 20%, indicating effective treatment for reduction of recurrent restenosis.
authors.affiliation: Medical Clinic I, University Aachen, Aachen, Germany. rhoffmann@ukaachen.de
authors.forename: Rainer
authors.initials: R
authors.lastname: Hoffmann
authors.forename: Roswitha
authors.initials: R
authors.lastname: Langenberg
authors.forename: Peter
authors.initials: P
authors.lastname: Radke
authors.forename: Harald
authors.initials: H
authors.lastname: Kühl
authors.forename: Jan
authors.initials: J
authors.lastname: Ortlepp
authors.forename: Rüdiger
authors.initials: R
authors.lastname: Blindt
authors.forename: Eberhard
authors.initials: E
authors.lastname: Grube
mesh_terms: D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D005060:Europe; D005260:Female; D006131:Growth Inhibitors / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage*; D011108:Polymers; D015607:Stents; D016896:Treatment Outcome
chemical_list: D006131:Growth Inhibitors; D011108:Polymers; D017239:Paclitaxel